Low-dose aspirin therapy for cardiovascular prevention: quantification and consequences of poor compliance or discontinuation.

Abstract

Long-term therapy with low-dose aspirin (acetylsalicylic acid; ASA), 75-325 mg, is highly effective for the secondary prevention of cardiovascular (CV) events. For high-CV-risk patients to attain the full benefits of this therapy, it is important that treatment is continuous and that good compliance is maintained over the long term. We aimed to quantify the… (More)
DOI: 10.2165/11318440-000000000-00000

Topics

3 Figures and Tables

Cite this paper

@article{Herlitz2010LowdoseAT, title={Low-dose aspirin therapy for cardiovascular prevention: quantification and consequences of poor compliance or discontinuation.}, author={Johan Herlitz and Peter P. Toth and J\orgen Naesdal}, journal={American journal of cardiovascular drugs : drugs, devices, and other interventions}, year={2010}, volume={10 2}, pages={125-41} }